Top compounds associated with response to CT45A9


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.004
mRNA barasertib CTRPv2 pan-cancer AAC -0.09 0.004
mRNA SRT-1720 CTRPv2 pan-cancer AAC -0.1 0.004
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.004
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.093 0.004
mRNA NSC 74859 CTRPv2 pan-cancer AAC -0.11 0.004
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.1 0.005
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.091 0.006
mRNA RG-108 CTRPv2 pan-cancer AAC -0.097 0.006
mRNA pifithrin-mu CTRPv2 pan-cancer AAC -0.093 0.006
Download CSV